Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023362
Filing Date
2024-09-13
Accepted
2024-09-13 16:15:17
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 form4-09132024_040908.html 4  
1 form4-09132024_040908.xml 4 3359
  Complete submission text file 0001415889-24-023362.txt   4805
Mailing Address C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025
Business Address
Horan Christopher (Reporting) CIK: 0001736819 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42179 | Film No.: 241297907

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)